There’s been distressing Ebola-related news in recent days. The deadly virus continues to spread in West Africa, with more than 4,500 fatalities now reported, and efforts to halt its spread in the U.S. have been mired in controversy and confusion, forcing... Read more »
A biotech company developing an injectable drug to shrink the excess fat that forms “love handles” says it plans to raise more than $63 million through an IPO.
San Diego-based Neothetics, previously known as Lithera, has substantial backing from Domain Associates... Read more »
For women trying to conceive, getting pregnant might not get easier in the next few months—but tracking their fertility to find the likeliest time to conceive might.
Kindara, a startup in Boulder, CO, recently announced the debut of Wink,... Read more »
Alumni of Gener8tor’s startup accelerator have been on a roll lately, and last night the program officially released its newest class into the wild with a closing event featuring pitches from the five graduating companies.
Now it’s up to the latest... Read more »
Hardly a day goes by without a big headline announcing yet another consumer security breach; today’s version trumpets the possible theft of Staples customers’ credit card information. Keeping payment information safe from criminals is a priority for both businesses and consumers,... Read more »
A developer of investment and analytics software for the online direct lending scene has raised some money of its own.
New York-based Orchard Platform on Tuesday announced it brought in $12 million in a Series A round led by Spark Capital... Read more »
Rhythm Pharmaceuticals hinted that a strategic move was coming when a drug it’s been developing for diabetic gastroparesis cleared a key clinical hurdle earlier this year. That came to fruition today, because Actavis has stepped and offered Rhythm a financial payday... Read more »
[Updated at 3:10 with a correction to revenue numbers provided.] Carl Prindle’s mission during the dot-com boom was to disrupt furniture companies. Now, he’s trying to help them sell their goods online.
As the CEO of Boston-based Blueport Commerce, Prindle has... Read more »
Katie Mehnert wants to leverage social media to support women in the energy industry.
An energy veteran who has worked for both BP (NYSE: BP) and Shell (NYSE: RSDA), she is now developing Pink Petro, a Facebook-like website that... Read more »
Proteon Therapeutics is about to successfully pivot from a potential portfolio company of Novartis to a publicly traded entity—just not with the valuation it was hoping for.
Waltham, MA-based Proteon priced its IPO late Tuesday at $10 per share. The company... Read more »